Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | ASND | BMRN | ||
| Company | Intra-Cellular Ther | Ascendis Pharma ADR | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 243.63 | 68.53 | ||
| High | 131.98 | 249.52 | 68.53 | ||
| Low | 131.63 | 240.64 | 67.12 | ||
| Last | 131.87 | 248.50 | 67.36 | ||
| Change | -0.05 | +2.27 | -1.17 | ||
| Percent Change | -0.04% | +0.92% | -1.71% | ||
| Volume | 16,062,900 | 650,300 | 1,413,400 | ||
| 20-Day Average Volume | 2,474,570 | 528,795 | 2,290,415 | ||
| Previous | 131.92 | 246.23 | 68.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 250.91 | 62.48 | ||
| 20-Day Raw Stochastic | 86.25% | 37.72% | 73.30% | ||
| 20-Day Relative Strength | 82.75 | 48.52 | 65.09 | ||
| Weighted Alpha | +83.21 | +24.65 | +25.62 | ||
| Today's Opinion | 100% Buy | 72% Buy | 96% Buy | ||
| Yesterday's Opinion | 100% Buy | 56% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | -2.71% since 08/07/26 | +5.56% since 08/07/26 | ||
| Low | 131.63 on 04/01/25 | 240.64 on 08/14/26 | 63.37 on 08/10/26 | ||
| High | 131.98 on 04/01/25 | 258.55 on 08/12/26 | 70.98 on 08/12/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | -6.43% since 07/14/26 | +14.87% since 07/14/26 | ||
| Low | 131.18 on 03/05/25 | 239.56 on 08/04/26 | 57.42 on 07/23/26 | ||
| High | 131.98 on 04/01/25 | 268.77 on 07/15/26 | 70.98 on 08/12/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +1.23% since 05/14/26 | +26.52% since 05/14/26 | ||
| Low | 80.82 on 01/07/25 | 203.80 on 06/08/26 | 49.26 on 05/18/26 | ||
| High | 131.98 on 04/01/25 | 282.15 on 07/09/26 | 70.98 on 08/12/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +14.88% since 02/13/26 | +12.51% since 02/13/26 | ||
| Low | 70.90 on 10/07/24 | 203.80 on 06/08/26 | 49.26 on 05/18/26 | ||
| High | 131.98 on 04/01/25 | 282.15 on 07/09/26 | 70.98 on 08/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 15,500,682 | 13,039,145 | ||
| Shares Outstanding, K | 106,522 | 62,377 | 193,574 | ||
| Annual Sales, $M | 680,850,000 | 814,760,000 | 3,221,250,000 | ||
| Annual Net Income, $M | -74,680,000 | -258,000,000 | 348,900,000 | ||
| Last Qtr Sales, $M | 199,220,000 | 288,620,000 | 989,710,000 | ||
| Last Qtr Income, $M | -16,890,000 | 736,580,000 | 44,760,000 | ||
| 60-Month Beta | 0.46 | 0.39 | 0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 0.32 on 05/07/26 | 1.20 on 08/06/26 | ||
| Latest Earnings Date | 05/06/25 | 11/11/26 | 10/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 136.79 | 40.79 | ||